This report focuses on four areas under congressional consideration deemed critical to the success of the biodefense enterprise: strategic planning; risk assessment; surveillance; and the development, procurement, and distribution of medical countermeasures. This report also discusses the effectiveness and sufficiency of programs implementing these aspects of the federal biodefense efforts, outside analysts' suggestions for improving the government's efforts, and current issues under congressional consideration
This report discusses the Project BioShield Act (P.L. 108-276), In 2004, passed by Congress to encou...
This report discusses the Project BioShield Act (P.L. 108-276), In 2004, passed by Congress to encou...
This report discusses the Project BioShield Act (P.L. 108-276), In 2004, passed by Congress to encou...
This report focuses on four areas under congressional consideration deemed critical to the success o...
This report focuses on four areas critical to the success of the biodefense enterprise that the 111t...
A letter report issued by the General Accounting Office with an abstract that begins "Federal resear...
This report focuses on the federal government's regulation of high containment laboratories. It expl...
Testimony issued by the General Accounting Office with an abstract that begins "Federal research and...
A statement of record issued by the General Accounting Office with an abstract that begins "Federal ...
Testimony issued by the General Accounting Office with an abstract that begins "Federal research and...
This report discusses the Project BioShield Act, In 2004, passed by Congress to encourage the privat...
This report discusses some aspects of the BioWatch Program which may be of particular interest to po...
This report discusses the Project BioShield Act (P.L. 108-276), In 2004, passed by Congress to encou...
This report discusses the Project BioShield Act (P.L. 108-276), In 2004, passed by Congress to enco...
This report discusses the Project BioShield Act (P.L. 108-276), In 2004, passed by Congress to encou...
This report discusses the Project BioShield Act (P.L. 108-276), In 2004, passed by Congress to encou...
This report discusses the Project BioShield Act (P.L. 108-276), In 2004, passed by Congress to encou...
This report discusses the Project BioShield Act (P.L. 108-276), In 2004, passed by Congress to encou...
This report focuses on four areas under congressional consideration deemed critical to the success o...
This report focuses on four areas critical to the success of the biodefense enterprise that the 111t...
A letter report issued by the General Accounting Office with an abstract that begins "Federal resear...
This report focuses on the federal government's regulation of high containment laboratories. It expl...
Testimony issued by the General Accounting Office with an abstract that begins "Federal research and...
A statement of record issued by the General Accounting Office with an abstract that begins "Federal ...
Testimony issued by the General Accounting Office with an abstract that begins "Federal research and...
This report discusses the Project BioShield Act, In 2004, passed by Congress to encourage the privat...
This report discusses some aspects of the BioWatch Program which may be of particular interest to po...
This report discusses the Project BioShield Act (P.L. 108-276), In 2004, passed by Congress to encou...
This report discusses the Project BioShield Act (P.L. 108-276), In 2004, passed by Congress to enco...
This report discusses the Project BioShield Act (P.L. 108-276), In 2004, passed by Congress to encou...
This report discusses the Project BioShield Act (P.L. 108-276), In 2004, passed by Congress to encou...
This report discusses the Project BioShield Act (P.L. 108-276), In 2004, passed by Congress to encou...
This report discusses the Project BioShield Act (P.L. 108-276), In 2004, passed by Congress to encou...